{"symbol": "BLPH", "companyName": "Bellerophon Therapeutics Inc.", "exchange": "NASDAQ Global Market", "industry": "Biotechnology", "website": "http://www.bellerophon.com", "description": "Bellerophon Therapeutics Inc is a clinical-stage biotherapeutics company. It develops products that are focused on the treatment of various types of pulmonary hypertension disorder.", "CEO": "Fabian Tenenbaum", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}